Mycophenolate Mofetil Can Effectively Induce Remission in EGPA

Mycophenolate Mofetil Can Effectively Induce Remission in EGPA

303254

Mycophenolate Mofetil Can Effectively Induce Remission in EGPA

Mycophenolate mofetil (MMF) is well-tolerated and can be used to induce remission in people with eosinophilic granulomatosis with polyangiitis (EGPA), a type of ANCA-associated vasculitis (AAV), a real-world study shows. Two-thirds of patients with newly diagnosed or relapsing EGPA achieved remission, or had no symptoms appearing for a time, within six months of using MMF, according to the study. The findings support recommendations for the use of MMF as an induction therapy across all types…

You must be logged in to read/download the full post.